N-3256

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameN-3256
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsVomitingNauseaMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNisshin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNisshin Pharma
Active IndicationsN/A
Inactive IndicationsVomitingNauseaMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A